NYSEAMERICAN:MYO - Myomo Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Myomo Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $5.57 -0.33 (-5.59 %) (As of 02/27/2020 02:02 AM ET) Add Compare Today's Range$5.46Now: $5.57▼$6.0550-Day Range N/A52-Week Range$5.28Now: $5.57▼$45.00Volume298,900 shsAverage Volume967,989 shsMarket Capitalization$3.19 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis used for the purpose of supporting a patient's weak or deformed arm to enable and improve functional activities of daily living, ADLs, in the home and community. Read More… Industry, Sector and Symbol Stock Exchange NYSEAMERICAN Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolNYSEAMERICAN:MYO Previous Symbol CUSIPN/A CIK1369290 Webhttp://myomo.com/ Phone+1-617-9969058Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees45 Outstanding Shares573,000Market Cap$3.19 million Next Earnings Date3/5/2020 (Estimated) OptionableNot Optionable Receive MYO News and Ratings via Email Sign-up to receive the latest news and ratings for MYO and its competitors with MarketBeat's FREE daily newsletter. AMEX:MYO Rates by TradingView Myomo (NYSEAMERICAN:MYO) Frequently Asked Questions What is Myomo's stock symbol? Myomo trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "MYO." How were Myomo's earnings last quarter? Myomo Inc (NYSEAMERICAN:MYO) released its quarterly earnings data on Tuesday, August, 7th. The company reported ($0.21) EPS for the quarter, missing analysts' consensus estimates of ($0.19) by $0.02. The firm had revenue of $0.63 million for the quarter, compared to the consensus estimate of $0.62 million. View Myomo's Earnings History. When is Myomo's next earnings date? Myomo is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for Myomo. What guidance has Myomo issued on next quarter's earnings? Myomo updated its fourth quarter 2019 After-Hours earnings guidance on Thursday, February, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.4-1.5 million, compared to the consensus revenue estimate of $1.09 million. What price target have analysts set for MYO? 2 equities research analysts have issued 1-year price targets for Myomo's stock. Their forecasts range from $2.00 to $2.00. On average, they anticipate Myomo's stock price to reach $2.00 in the next twelve months. This suggests that the stock has a possible downside of 64.1%. View Analyst Price Targets for Myomo. What is the consensus analysts' recommendation for Myomo? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Myomo in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Myomo. Has Myomo been receiving favorable news coverage? Media headlines about MYO stock have trended somewhat positive on Thursday, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Myomo earned a media sentiment score of 2.0 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the next several days. View News Stories for Myomo. Are investors shorting Myomo? Myomo saw a decrease in short interest during the month of February. As of February 14th, there was short interest totalling 31,300 shares, a decrease of 94.5% from the January 30th total of 567,700 shares. Based on an average trading volume of 247,100 shares, the short-interest ratio is presently 0.1 days. Currently, 6.1% of the company's shares are sold short. View Myomo's Current Options Chain. Who are some of Myomo's key competitors? Some companies that are related to Myomo include GI Dynamics (GID), LBT Innovations (LBT), Universal Biosensors (UBI), Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Azure Healthcare (AZV), Titan Medical (TMD), Prairie Provident Resources (HCYT), Surgical Innovations Group (SUN), Total Brain (TTB), Osprey Medical (OSP), Aurora Spine (ASG), Heramed (HMD), Analytica (ALT) and Micron Solutions (MICR). What other stocks do shareholders of Myomo own? Based on aggregate information from My MarketBeat watchlists, some companies that other Myomo investors own include Genocea Biosciences (GNCA), Synergy Pharmaceuticals (SGYP), Sarepta Therapeutics (SRPT), Protalix Biotherapeutics (PLX), Agile Therapeutics (AGRX), Anavex Life Sciences (AVXL), Remark (MARK), Abeona Therapeutics (ABEO), Aclaris Therapeutics (ACRS) and Aduro BioTech (ADRO). Who are Myomo's key executives? Myomo's management team includes the folowing people: Mr. Paul R. Gudonis, Chairman, Pres & CEO (Age 64)Mr. Jonathan Naft, VP & GM (Age 54)Mr. David A. Henry, Chief Financial Officer (Age 58)Mr. Clifford J. Conneighton, Chief Marketing Officer (Age 69)Dr. Brandon Green DO, BOCP, Chief Medical Officer (Age 72) Who are Myomo's major shareholders? Myomo's stock is owned by many different of institutional and retail investors. Top institutional investors include ICM Asset Management Inc. WA (87.78%) and Renaissance Technologies LLC (70.49%). Company insiders that own Myomo stock include David A Henry and Paul R Gudonis. View Institutional Ownership Trends for Myomo. Which institutional investors are buying Myomo stock? MYO stock was acquired by a variety of institutional investors in the last quarter, including ICM Asset Management Inc. WA and Renaissance Technologies LLC. Company insiders that have bought Myomo stock in the last two years include David A Henry and Paul R Gudonis. View Insider Buying and Selling for Myomo. How do I buy shares of Myomo? Shares of MYO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Myomo's stock price today? One share of MYO stock can currently be purchased for approximately $5.57. How big of a company is Myomo? Myomo has a market capitalization of $3.19 million. Myomo employs 45 workers across the globe.View Additional Information About Myomo. What is Myomo's official website? The official website for Myomo is http://myomo.com/. How can I contact Myomo? Myomo's mailing address is One Broadway, 14Th Floor, CAMBRIDGE, MA 02142, United States. The company can be reached via phone at +1-617-9969058. MarketBeat Community Rating for Myomo (NYSEAMERICAN MYO)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 144 (Vote Outperform)Underperform Votes: 128 (Vote Underperform)Total Votes: 272MarketBeat's community ratings are surveys of what our community members think about Myomo and other stocks. Vote "Outperform" if you believe MYO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MYO will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/27/2020 by MarketBeat.com StaffFeatured Article: What is a stock split?
